Data / Drug companies / Sulfonylurea
Sulfonylurea drugs: 8 drugs from 63 companies in the FDA NDC directory
Sulfonylurea is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 359 products in this class from 63 companies, covering 8 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 63Companies
- 359Products
- 8Drugs by generic name
Drugs in the Sulfonylurea class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Glipizide | 145 | 39 |
| Glimepiride | 105 | 32 |
| Glyburide | 54 | 17 |
| Glyburide and metformin hydrochloride | 21 | 9 |
| Glipizide and metformin hydrochloride | 14 | 6 |
| Glyburide-metformin hydrochloride | 9 | 5 |
| Glipizide and metformin hcl | 7 | 3 |
| Pioglitazone and glimepiride | 4 | 2 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 48 | tablet; tablet, extended release | Generic drugs (ANDA) | May 1, 2025 |
| Bryant Ranch Prepack | 28 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | May 1, 2025 |
| NuCare Pharmaceuticals,Inc. | 22 | tablet; tablet, film coated | Generic drugs (ANDA) | May 1, 2025 |
| Preferred Pharmaceuticals Inc. | 19 | tablet; tablet, film coated | Generic drugs (ANDA) | September 24, 2026 |
| Remedyrepack Inc. | 15 | tablet; tablet, extended release | Generic drugs (ANDA) | October 15, 2026 |
| Northwind Health Company, LLC | 12 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | June 27, 2023 |
| Teva Pharmaceuticals USA, Inc. | 11 | tablet; tablet, film coated | Generic drugs (ANDA) | October 28, 2005 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | May 1, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 9 | tablet | Generic drugs (ANDA) | January 1, 2012 |
| Zydus Lifesciences Limited | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | June 2, 2016 |
| Zydus Pharmaceuticals USA Inc. | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | June 2, 2016 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet | Generic drugs (ANDA) | October 9, 2026 |
| Proficient Rx LP | 8 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Aurobindo Pharma Limited | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | June 29, 2012 |
| Chartwell RX, LLC | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | October 5, 2010 |
| Micro Labs Limited | 6 | tablet | Generic drugs (ANDA) | June 13, 2013 |
| Proficient Rx LP | 6 | tablet | Generic drugs (ANDA) | May 1, 2025 |
| AiPing Pharmaceutical, Inc. | 5 | tablet | Generic drugs (ANDA) | October 9, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet | Generic drugs (ANDA) | August 17, 2009 |
| AvPAK | 5 | tablet | Generic drugs (ANDA) | July 10, 2020 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet | Generic drugs (ANDA) | June 13, 2013 |
| Rising Pharma Holdings, Inc. | 5 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | October 30, 2026 |
| Advagen Pharma Ltd | 4 | tablet | Generic drugs (ANDA) | October 3, 2023 |
| American Health Packaging | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | April 4, 2025 |
| Bryant Ranch Prepack | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | March 3, 2023 |
| Coupler LLC | 4 | tablet | Generic drugs (ANDA) | June 10, 2026 |
| Proficient Rx LP | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | June 29, 2012 |
| St. Mary's Medical Park Pharmacy | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | June 12, 2024 |
| Accord Healthcare Inc. | 3 | tablet | Generic drugs (ANDA) | August 23, 2007 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | July 21, 2014 |
| Aurobindo Pharma Limited | 3 | tablet, extended release | Generic drugs (ANDA) | March 3, 2023 |
| BluePoint Laboratories | 3 | tablet | Generic drugs (ANDA) | September 1, 2023 |
| Cadila Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | April 26, 2014 |
| Carlsbad Technology, Inc. | 3 | tablet | Generic drugs (ANDA) | January 1, 2012 |
| Dr. Reddy's Laboratories Limited | 3 | tablet | Generic drugs (ANDA) | October 6, 2005 |
| Florida Pharmaceutical Products, LLC | 3 | tablet | Generic drugs (ANDA) | July 31, 2023 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | September 22, 2009 |
| Modavar Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| NorthStar Rx LLC | 3 | tablet, extended release | Generic drugs (ANDA) | December 1, 2018 |
| Northwind Health Company, LLC | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | January 26, 2024 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | November 14, 2007 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | June 29, 2012 |
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | January 30, 2017 |
| Actavis Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | February 27, 1995 |
| Advanced Rx of Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | August 29, 2025 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 31, 2022 |
| Apotex Corp. | 2 | tablet | Generic drugs (ANDA) | September 25, 2002 |
| AvKARE | 2 | tablet, film coated | Generic drugs (ANDA) | July 8, 2013 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | October 6, 2005 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | April 22, 2009 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | September 26, 2024 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | August 31, 1995 |
| Legacy Pharmaceutical Packaging, LLC | 2 | tablet | Generic drugs (ANDA) | September 25, 2002 |
| NuCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Oxford Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | May 1, 2025 |
| Prasco Laboratories | 2 | tablet | Authorized generics (NDA) | August 4, 2015 |
| Takeda Pharmaceuticals America, Inc. | 2 | tablet | New drug applications (NDA) | July 28, 2006 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | February 27, 1995 |
| Lifsa Drugs LLC | 1 | tablet | Generic drugs (ANDA) | August 20, 2024 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 25, 2002 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | February 27, 1995 |
| Roerig | 1 | tablet, extended release | New drug applications (NDA) | May 9, 2013 |
| TruPharma, LLC | 1 | tablet | Generic drugs (ANDA) | October 3, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 284 | 79.1% |
| Tablet, film coated | 36 | 10% |
| Tablet, extended release | 24 | 6.7% |
| Tablet, film coated, extended release | 15 | 4.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.